Table 1.

Clinical details of sequencing patients enrolled in MeDIP-seq, hMeDIP-seq, small RNA-seq, and mRNA array

Sample No.	Age, y	Sex	Pathological Diagnosis	Surgical Excision	Treatment	AFP	HCG	MeDIP- seq	hMeDIP- seq	smRNA- seq	mRNA Array
G1	14.1	M	G	STR	RT	N	N	+	+	+	+
G2	11.6	M	G	PR	RT	N	N	+	+	–	+
G3	13.9	M	G	NTR	RT	N	N	+	+	+	–
G4	14.0	M	G	PR	RT+CMT	H	N	+	+	+	+
G5	11.4	F	G	PR	RT	N	N	+	+	+	–
G6	12.4	M	G	PR	RT	N	N	+	+	+	–
G7	16.0	M	G	STR	RT	N	N	–	–	+	+
G8	12.2	M	G	PR	RT	N	N	–	–	–	+
G9	10.4	F	G	PR	RT	N	N	–	–	–	+
NG1	11.5	M	MGCT	STR	RT+CMT	H	N	+	+	+	–
			(G+IT+YSC)
NG2	4.3	M	MGCT	NTR		N	N	+	–	–	+
			(G+IT)
NG3	0.7	M	IT	NTR	RT+CMT	H	N	+	+	+	–
NG4	14.5	M	MGCT	PR	RT+CMT	H	N	+	+	+	+
			(G+YSC)
NG5	7.6	M	MGCT	NTR	RT+CMT	H	H	+	+	+	+
			(EC+IT+YSC)
NG6	10.3	M	MGCT	NTR	RT+CMT	N	N	+	+	+	+
			(IT+G)
NG7	0.0	F	IT	NTR		H	N	–	+	+	+
NG8	0.1	F	IT	NTR	RT+CMT	H	N	–	–	+	–
NG9	10.6	M	MGCT	PR	RT+CMT	H	H	–	–	–	+
			(IT+YSC)

Abbreviations: G, germinoma; NTR, near total removal, >95%; MGCT, mixed GCT; STR, subtotal removal, >75%; IT, immature teratoma; PR, partial removal, >25% <75%; YSC, yolk sac tumor; RT, radiotherapy; CMT. chemotherapy; normal range of AFP <10 ng/dL; EC, embryonal carcinoma; normal range of betaHCG <10 mIU/dL; “+”: sequenced; “‒”: not sequenced; NG, NGMGCTs or nongerminomatous malignant germ cell tumors; N, normal level; H, high level.